Panel | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
|
...
CVX Code | Vaccine Name | Component | Component |
---|---|---|---|
22 | DTP-Hib (Tetramune; OmniHib-DTP) | 17 | Hib NOS |
50 | DTaP-Hib (TriHiBit) | 48 | Hib-PRP-T |
51 | Hep B-Hib (PRP-OMP (ComVAX) | 49 | Hib-PRP-OMP |
102 | DTP-Hib-Hep B | 17 | Hib NOS |
120 | DTaP-Hib-IPV | 48 | Hib-PRP-T |
132 | DTaP-IPV-Hib-Hep B, historical | 17 | Hib NOS |
146 | DTaP, IPV, Hib, Hep B | 17 | Hib NOS |
148 | Meningococcal C/Y-HIB PRP (Menhibrix) | 48 | Hib-PRP-T |
170 | DTaP-IPV-Hib | 48 | Hib-PRP-T |
198 | DTP-Hep B-Hib Pentavalent, Non-US | 17 | Hib NOS |
Immunization Series and Selection Rules
...
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Hib 4-dose | 38 days | 42 days (6 weeks) | 2 months | 3 months + 4 weeks | 17, 46, 47, 48, 49, 51, 120, 22, 148, 102, 132, 146, 170, 198 | 501 |
2 | Hib 4-dose | 66 days | 70 days (10 weeks) | 4 months | 5 months + 4 weeks | 17, 46, 47, 48, 49, 51, 120, 22, 148, 102, 132, 146, 170, 198 | 501 |
3 | Hib 4-dose | 94 days | 98 days (14 weeks) | 6 months | 7 months + 4 weeks | 17, 46, 47, 48, 49, 51, 120, 22, 148, 102, 132, 146, 170, 198 | 501 |
4 | Hib 4-dose | 1 year - 4 days | 12 months | 12 months | 16 months + 4 weeks | 17, 46, 47, 48, 49, 51, 120, 22, 148, 102, 132, 146, 170, 198 | N/A |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Minimum Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Hib 4-dose | 24 days | 28 days | 28 days | 16 weeks |
Dose 2 to 3 | Hib 4-dose | 24 days | 28 days | 28 days | 16 weeks |
Dose 3 to 4 | Hib 4-dose | 52 days | 56 days | 56 days | 10 months + 4 weeks |
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Special RulesHib 4-dose Series Exception Rules
Follow the Hib 4-dose series tables (above) unless one of the following exceptions applies:
- Or -
- Or -
Hib 4-dose Series Rule for CVX 50
|
...
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Hib OMP | 38 days | 42 days (6 weeks) | 2 months | 3 months + 4 weeks | 49, 51 | 17, 46, 47, 48, 120, 22, 148, 50, 102, 132, 146, 170, 198 |
2 | Hib OMP | 66 days | 70 days (10 weeks) | 4 months | 5 months + 4 weeks | 49, 51 | 17, 46, 47, 48, 120, 22, 148, 50, 102, 132, 146, 170, 198 |
3 | Hib OMP | 1 year - 4 days | 12 months | 12 months | 16 months + 4 weeks | 17, 46, 47, 48, 49, 50, 51, 120, 22, 148, 102, 132, 146, 170, 198 |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Minimum Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Hib OMP | 24 days | 28 days | 28 days | 16 weeks |
Dose 2 to 3 | Hib OMP | 52 days | 56 days | 56 days | 10 months + 4 weeks |
...